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Abstract: The main objective of this study was to assess PAG2 mRNA expression in maternal
blood cells at the peri-implantation period in water buffalo; moreover, we wanted to evaluate the
earliest time in which PAG-2 could be detected in maternal blood. Thirty-two lactating buffaloes
artificially inseminated (AI) were utilized. Blood was collected at Days 0, 14, 18, 28, 40 after AI
(AI = day 0). Pregnancy was diagnosed by ultrasound at Days 28 and 40 post AI. Out of 32 buffaloes,
14 were pregnant (P group) and 18 were not pregnant (NP group). The plasma PAG-2 threshold of
1.0 ng/mL in the P group was reached at day 40 post AI. PAG2 mRNA expression differed between
the P and NP groups, and was either evaluated in Peripheral Blood Mononuclear Cells (PBMC) or
Polymorphonuclear Leukocytes (PMN), starting from day 14. However, both the estimated marginal
means and multiple comparisons showed that PAG2 mRNA expression was higher in PMN than
PBMC. In the present study, PAG-2 appeared in the blood (40 Days post AI), and an early expression
of PAG2 mRNA at Day 14 post AI was also observed. Although further research is undoubtedly
required, PAG2 mRNA in peripheral blood leukocytes could be using to better understand the role
that PAGs play during pregnancy in buffalo.
Keywords: PAG2 mRNA; peri-implantation; pregnancy diagnosis; water buffalo
1. Introduction
Pregnancy-associated glycoproteins (PAGs) constitute a large aspartic Proteinase family of
glycoproteins expressed in the outer epithelial layer of the placenta in eutherian species [1–3], and
are particularly numerous in ruminant ungulates. They are probably involved in proper placenta
development and embryo maternal interaction in Eutherian mammals.
In ruminants, the PAG gene family is particularly large and complex. Dozens of distinct
cDNAs, and numerous variants, have been cloned from cattle, sheep, goat, bison, buffalo and deer
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placentae [4–16]. The PAG gene family in ruminants is comprised of two evolutionarily distinct
groups [8,17,18]. Based on the time when each group arose, phylogenetically PAGs can be defined
as ancient (PAG-2), that is, they originated 87 million years ago, and modern (PAG-1) that are
estimated to have originated 52 million years ago [8,13,17,19]. Bovine PAG-2 coexists with bovine
pregnancy-associated glycoprotein 1 in the trophectoderm [8,19–21] and their functions are not
completely understood [20,22]. PAG-1 are produced in binucleate cells of both intercotiledonary
and cotyledonary chorion, while PAG-2 molecules are produced by both mononucleate and binucleate
trophoblastic cells [23]. The majority of PAGs belong to the modern group and these have only been
observed in the Ruminantia [13,21]. Although the functions of these glycoproteins are not yet fully
understood, plasma PAG-I concentrations have been used for pregnancy diagnosis and as a marker
of placental/fetal well-being [6,21,24–27]. Water buffalo PAG-1 concentrations can be detected in the
blood of pregnant females around Day 28 and 30 of gestation by radioimmunoassay (RIA) [15,28–30].
Very recently, a new approach was described in which an antiserum was raised against boPAG-2
allowing PAG molecules to be detected in maternal blood [31–35] in bovine species. For the buffalo
species, eleven PAG molecules from group-I were purified and characterized from water buffalo
placenta (wbPAG) [15,28–30] while 19 different complementary DNA (cDNA) of PAG genes were
identified in this species [36]. With regard to expression of the PAG-II group, by using real time PCR
technique, it was demonstrated that PAG2 mRNA can be detected in placenta as early as 17–19 days
of pregnancy, coinciding with the beginning of implantation in the bovine placenta [3], 18 days in
caprine [7], and 13 days in ovine [8]. Barbato et al. [36] were the first to investigate mRNA PAG-2
expression in blood during early pregnancy in water buffalo. No investigation have been carried out
on the quantification of PAG2 mRNA expression in specific blood cells.
The main objective of this study was to assess PAG2 mRNA expression in the maternal subset of
blood leukocytes at the peri-implantation period in water buffalo; moreover, we wanted to evaluate
the earliest time in which PAG-2 could be detected in maternal blood.
2. Materials and Methods
2.1. Animals and Experimental Design
This study was carried out at the CREA Centro di ricerca Zootecnia e Acquacoltura experimental
farm, located near Rome, Italy (42◦3′ N, 12◦37′ E), from February to April 2015 during the
daylight-lengthening period, which represents the transition from the breeding to the nonbreeding
season for this species. The animals involved in this trial were supervised in compliance with Italian
laws and regulations regarding experimental animals. The experimental design was performed
according to good veterinary practices under farm conditions. The CREA Centro di ricerca Zootecnia
e Acquacoltura is authorized to use farm animals for experimental design (as stated in DM 26/96-4
of Italian Welfare Ministry). Thirty-two lactating Italian Mediterranean buffalo cows were used to
determinate the PAG concentrations and RNA isolation. The animals were housed in an open paddock,
fed ad libitum on total mixed rations based on maize silage, alfalfa hay, soya bean meal, maize meal
and barley meal (containing 0.90 UFL/Kg of dry matter (DM) and 15% crude protein on DM) and
milked twice daily.
The buffalo cows were treated with a progesterone-releasing intravaginal device (PRID®; Sanofi,
France), containing 1.55 g natural progesterone kept in place for 10 days. At the time of PRID
withdrawal an i.m. injection of 500 IU of PMSG (Ciclogonina®, Pfizer, Latina, Italy) and 0.15 mg
of cloprostenol (PGF2α analogue) (Dalmazin®, FATRO, Ozzano Emilia, Bologna, Italy) were given.
The evening before artificial insemination (AI) buffaloes were treated intramuscularly with 150-ug
gonadorelin (GnRH, Enagon; Intervet, Aprilia, Latina, Italy). Animals were artificially inseminated
using frozen-thawed semen at 72 h after PRID® removal.
Blood was collected from the jugular vein into 10 mL EDTA coated tubes at Days 0, 14, 18, 28
and 40 after AI (AI = day 0). Day 0 was considered as the control day. For cell isolation, blood
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samples were immediately processed. The isolated Peripheral Blood Mononuclear Cell (PBMC) and
Polymorphonuclear Leukocytes (PMN) were stored at −80 ◦C until qRNA extraction. For PAG-2
determination, plasma was separated by centrifugation at 2500× g for 10 min, and stored at −20 ◦C
until assayed.
2.2. Pregnancy Diagnosis
Pregnancy diagnosis was performed on Day 28 and Day 40 after AI by transrectal ultrasonography
(Aloka–SSD Prosound 2 scanner, Hitachi Medical System, Italy) with a 7.5 MHz linear-array transducer.
All ultrasound scans were performed by the same operator. Positive pregnancy status at Day 28 and
Day 40 were characterized by the presence of embryonic vesicles and embryo proper within the vesicle
and the heartbeat visualization (embryo viability) [37]. In the absence of embryonic vesicle or embryo
proper in the uterine lumen at Day 28 and Day 40, females were considered as non-pregnant.
2.3. PAG-2 Radioimmunoassay
The bovine PAG-2 radioimmunoassay used has been described recently in [31,34,38]. Briefly,
PAG-2 was purified according to the method detailed by Beckers et al. [39]. The primary antibody was
rabbit polyclonal antiserum against boPAG-2 (AS#438) raised as described by Vaitukaitis et al. [40].
Owing to the instability of the boPAG-2 molecule, boPAG-1 (67 kDa) was used as a standard (dilutions
ranging from 100 to 0.2 ng/mL) and for iodination with the 125-I isotope [41]. The initial dilution for
primary AS#438 was 1:2500. The minimum detection limit calculated for RIA-438 was 2.1 ng/mL. The
intra- and inter-assay coefficients were 4.2% and 4.5%, respectively. Plasma PAG concentrations that
were over 1 ng/mL were considered indicative of the presence of a secreting trophoblast.
2.4. Isolation of PBMC and PMN
The blood samples (10 mL) were taken from the external jugular vein and placed in vacutainer
tubes containing anticoagulant EDTA and processed within 1 h. PBMC were isolated by density
gradient (Lymphoprep™; 1.077 g/mL; AXIS-SHIELD). In briefly, 8 mL of Lymphoprep was placed
into a 50 mL Falcon® tube and an equal volume of whole blood diluted 1:1 with Hank’s Buffered Salt
Solution (HBSS without Ca2+ and Mg2+) was carefully layered on the gradient. The Falcon® tube,
containing two-step gradient of Lymphoprep and blood, was centrifuged at 800× g for 30 min and
then washed twice with HBSS. The PMN and erythrocytes sedimented through the Lymphoprep layer
during centrifugation. The erythrocytes were then lysed with 1:10 v/v of 1× Ammonium Chloride
lysing solution (10× stock solution: NH4Cl 80 g, KHCO3 10 g, Na4EDTA 3.7 g, final volume 1 L)
and washed once with Phosphate Buffer Solution (PBS). The supernatant was aspirated carefully
without disturbing the pellet and resuspended in PBS. The purity of the PBMC and PMN fractions
were evaluated by flow cytometry. Cell subtypes were identified based on their FSC and SSC scatter,
and auto-fluorescent properties. The purity of PBMC and PMN was 99% and 80%, respectively.
2.5. RNA Isolation Reverse Transcription and qPCR
Total RNA was isolated from PBMC and PMN cells with RNeasy® Micro or Mini Kit purification
system (Qiagen, Hombrechtikon, Switzerland) following manufacturer’s recommendations. The
concentration of RNA was checked by analyzing the OD260/OD280 ratio. The RNA quality was
then determined based on agarose gel electrophoresis and the RNA quantity was evaluated by
Qubit Fluorometric Quantitation (Life Technologies, Carlsbad, CA, USA). RNA was stored at −80 ◦C
until use.
Total RNA (15 ng) was reverse transcribed with iScript cDNA Synthesis Kit (BioRad, Hercules,
CA, USA) according to the manufacturer’s protocol.
QPCR were performed according to the method described by [42]. The optimized qPCR assays
contained 10 µL TaqMan Gene Expression Master Mix (Applied Biosystems, Foster City, CA, USA),
1 µL TaqMan Gene Expression Assays (Applied Biosystems, Foster City, CA, USA) and water to
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achieve in a final volume of 20 µL. The probe sequences that were used are listed in Table 1. All
reagents were mixed and distributed into a 96-well qPCR plate before adding 4 µL of diluted cDNA
(1:10 with water). Each sample was run in triplicate and the results were averaged. In parallel, to assess
the non-specific amplicon (primer-dimer formation) or genomic DNA contamination, no template
control and no reverse transcriptase control were evaluated. PCR reactions were performed on iCycler
iQ (Bio-Rad, Hercules, CA, USA) with an initial incubation at 95 ◦C for 10 min, followed by 45 cycles
at 95 ◦C for 15 s and 60 ◦C for 60 s, during which time fluorescence data were collected. Prior to
sequencing, PCR products were purified by QIAquick PCR Purification Kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions. Normalization of qPCR data was performed referring the
selected targets ACTB by using the 2−∆Ct method (∆Ct = Ct target mRNA − Ct ACTB). The stability
of the candidate reference genes was evaluated through the BestKeeper algorithm [36].
Table 1. TaqMan Gene Expression assays used in the studies are listed by assay numbers. The TaqMan
Gene Expression assay is composed of a pair of unlabelled PCR primers and a probe with a FAM dye
label on the 5′ end, and a minor groove binder (MGB) non-fluorescent quencher (NFQ) on the 3′ end.
Name Sequence Exons Connected Amplicon
Pregnancy-Associated Glycoprotein 2 (PAG2) BOS
9-9 127 bpTaqMan Bt03292796_gH NM_176614.1
Actin beta(ACTB) BOS
4-5 144 bpTaqMan Bt03279175_g1 NM_173979.3
2.6. Statistical Analysis
Diagnostic graphics were used for testing assumptions and outliers. Because non-normality of
the data was detected, Log(x + 1) transformation were used for analysis and the back-transformed
estimated marginal means were presented. The figures show raw data. The data were analyzed
using the Linear Mixed model in which animals and days were included as subjects and repeated
factors, respectively. Sidak adjustment was used for carrying out multiple comparisons. The model for
PAG-2 concentrations determined by the RIA system evaluated the main effects of time (5 levels: 0,
14, 18, 28, and 40 Days post AI), outcome (2 levels: Pregnant and Non-Pregnant), and the interaction
between outcome and time. To analyse the expression of PAG-2 in PMN and PBMC, the model
evaluated the effects of time (5 levels: 0, 14, 18, 28, and 40 Days post AI), outcome (2 levels: Pregnant
and Non-Pregnant), cell type (2 levels: PMN and PBMC), and their interactions. In order to test the
ability of PAG-2 expression in PMN and PBMC to discriminate between pregnant and non-pregnant
outcomes in early pregnancy, we performed the Receiver Operating Characteristic (ROC) analysis
and we determined the optimal cut-off by using the Youden index [43]. Finally, we calculated the
sensitivity and specificity at each day and for all the parameters. Statistical analyses were performed
with SPSS Statistics version 23 (IBM, SPSS Inc., Chicago, IL, USA). Statistical significance occurred
when p < 0.05.
3. Results
By ultrasound examination, of the 32 inseminated buffaloes used in the present study, 14 were
confirmed to be pregnant and 18 were non-pregnant.
3.1. PAG-2 Concentrations Determined by RIA System in Pregnant and Non-Pregnant Buffaloes
No differences were observed in ln-PAG-2 between pregnant and non-pregnant groups until day
28 post AI, when it was 0.0 ± 0.0 ng/mL and 0.3 ± 0.1 ng/mL in non-pregnant and pregnant groups,
respectively (p < 0.01; Figure 1). In non-pregnant buffaloes, ln-PAG-2 remained constantly close to
0.0 ng/mL throughout the observation period, while in pregnant animals they were significantly
different to day 0, starting from day 28 post AI (p < 0.05). However, the mean concentrations reached
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the threshold for the diagnosis of pregnancy (1.0 ng/mL) only at day 40 post AI (Figure 1), when
sensitivity and specificity were 78.6% and 100.0%, respectively (Table 2).
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Figure 1. PAG-2 concentrations until Day 40 post AI in the pregnant and non-pregnant group
(mean ± SE, row data) evaluated with the radioimmunoassay (RIA) system. *** p < 0.001. ** p < 0.01
Pregnant vs. No -pregnant at each day (Sidak c rrection). The dotted line indicates the threshold for
the c diagnosis (1.0 ng/mL).
Table 2. Sensitivity, specificity, and accuracy of PAG-2 determined by RIA for pregnancy diagnosis in
buffaloes 14, 18, 28, and 40 days post-insemination (threshold = 1.0 ng/mL).
Day Diagnosis
Outco
Sensitivity Specificity Ac uracyNon-Pregnant
(n = 18)
Pregnant
(n = 14)
14
Non-Pregnant 18(100.0%)
14
(100.0%) 0.00% 100.00% 56.30%
Pregnant 0(0.0%)
0
(0.0%)
18
Non-Pregnant 18(100.0%)
13
(92.9%) 7.10% 100.00% 59.40%
Pregnant 0(0.0%)
1
(7.1%)
28
Non-Pregnant 18(100.0%)
11
(78.6%) 21.40% 100.00% 65.60%
Pregnant 0(0.0%)
3
(21.4%)
40
Non-Pregnant 18(100.0%)
3
(21.4%) 78.60% 100.00% 90.60%
Pregnant (0.0%)
11
(78.6%)
1 Determined ex post on the basis of pregnancy diagnosis by ultrasonography at day 28 and 40.
3.2. PAG2 Expression in PMN and PBMC in Pregnant and Non-Pregnant Buffaloes
The Basic Local Alignment Search Tool analysis of the amplicon sequence for the retrieval of
the gene sequences showed 100% similarity with the sequences PAG2 (ID: NM_176614.1) and ACTB
(Bt03292796_gH).
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Expression of PAG2 (as 2−∆Ct) was affected by Time (p < 0.001), Group (p < 0.001), Cell type
(p < 0.001), and interaction between Time and Group (p < 0.001; Figure 2). The estimated marginal
means of expression of PAG2 was higher in Pregnant than Non-pregnant group (2.3± 0.1 and 0.45± 0.1,
respectively; p < 0.001) and in PMN than PBMC (1.5 ± 0.1 and 0.9 ± 0.1, respectively; p < 0.001).
1 
 
 
 
 
Figure 2. PAG2 expression in granulocytes (PMN, 2−∆Ct; Upper Panel) and peripheral blood
mononuclear cells (PBMC, 2−∆Ct; Lower Panel) until Day 40 post AI in the Pregnant and Non-pregnant
group (mean ± SE, raw data). Differences, in both PMN and PBMC expression, between the Pregnant
and Non-pregnant group as well as with respect to Day 0, starting from Day 14 post artificial
insemination (AI; *** p < 0.001 Pregnant vs. Non-pregnant and each day of observation vs. Day 0).
Differences both in PMN and PBMC expression of PAG2 between the Pregnant and Non-pregnant
groups was significant from Day 14 (p < 0.001; Figure 2). Similarly, the differences with respect to
Day 0 started from Day 14 for both PMN and PBMC (p < 0.001; Figure 2).
Multiple comparisons also showed that in the Pregnant group, PMN was higher than PBMC
starting from Day 14 (p < 0.05), although, PMN showed higher variability (Figure 3).
Both PMN and PBMC discriminated perfectly between pregnant and non-pregnant buffaloes
from Day 14 until the last day of observation (AUC = 1.000; CI 95%: 1.000–1.000; p < 0.05). The cut
off was 0.59 and 0.70 at Day 14, 3.04 and 2.27 at Day 18, 2.10 and 1.62 at Day 28, and 3.50 and 1.60 at
Day 40 post AI for PMN and PBMC, respectively (sensitivity = 100%, specificity = 100%).
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4. Discussion
To our knowledge, no studies have been carried out on the mRNA expression of PAG2 in
peripheral blood leukocytes. The rationale for this work was to verify the expression of PAG2 mRNA
in maternal blood cells. We observed an early expression of PAG2 mRNA, both in PMN and PBMC, at
Day 14 post AI in all buffaloes that were diagnosed pregnant, although the expression was higher in
the PMN than in the PBMC throughout the period of observation. This early expression confirmed our
previous observations on this species [29]. We found that PAG2 mRNA expression in maternal blood
was detected at 18 Days after AI. These findings were in agreement with Xie et al. [3], who reported the
expression of PAG–2 mRNA in bovine placenta as early as 17–19 days of pregnancy, Garbayo et al. [7]
at 18 days in caprine and Green et al. [8] at 13 days of gestation in sheep.
The peri-implantation period is an extremely delicate time in the establishment of pregnancy
in which various mechanisms are involved in maintaining a functional corpus luteum. It is
generally accepted that pregnancy recognition in dom stic ruminants is a local phenomenon involving
IFN-stimulated genes (ISG). Recently, various works have demonstrat d the pre ence of a viable
conceptus by measuring levels of ISG in materna periph ral blood leukocy es 15 d ys after
insemination in he p [44], 18 days after AI in dairy cattle [45] a d between 15 and 20 days after
AI in beef cattle [46]. The interferon tau (IFN-τ) is the major paracrine factor inv lved in pregnancy
recognition in ruminant species [47–49]. Both PAG-2 and IFN-τ are Day 7/Day 14 and Day 14/
Day 21 up-regulated genes in bovine conceptus, respectively [50]. Our study has highlighted the
presence of mRNA PAG2 expression in peripheral leukocytes, like ISG, therefore our hypothesis is
that this glycoprotein could be involved in the process of maintaining the functional corpus luteum,
and therefore, in the process of establishing the pregnancy. Moreover, different authors [51–55]
have hypothesized that PAGs may also have an indirect role in the complex process of maternal
recognition and maintenance of pregnancy through the increase in prostaglandin E2 and progesterone
synthesis [56,57]. Furthermore, PAGs may have an additional role in inducing the increase in GPC-2
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(granulocyte chemotactic protein-2) by bovine endometrial cells, which is involved in the establishment
of pregnancy [58,59]. It remains to be clarified why the expression of PAG2 mRNA appears to be higher
in PMN than in PBMC.
To our knowledge, this is the first work in which the plasma concentration of PAG molecules
during the gestation period was measured using antibodies raised against PAG-2 in buffalo, although,
there are various works in which this method has been reported for bovine species [31,32,34,35].
Although significant differences were found starting from Day 28 post AI, our results show that the
threshold value for pregnancy diagnosis (1.0 ng/mL) was only reached at Day 40 post AI, as previously
reported for bovine species in [31,32,34,35]. Therefore, this work confirmed that in buffalo as well, the
pre-eminent PAG radioimmunoassay method to diagnose pregnancy utilizes antibodies raised against
PAG-1, as reported in our previous work [26,29,30].
5. Conclusions
In conclusion, the plasma PAG-2 threshold of 1.0 ng/mL was reached a Day 40 post AI in pregnant
water buffalo, whereas expression of PAG2 mRNA at Day 14 post AI was observed in peripheral blood
leukocytes. Our results suggest that although further research is undoubtedly required to confirm
these findings, PAG2 mRNA in peripheral blood leukocytes could be used to better understand the
role that PAGs play during pregnancy in buffalo, and even in other ruminant species.
Furthermore, in the future, the quantification of PAG2 mRNA expression in blood leukocytes
could be used to differentiate pregnant and non-pregnant buffaloes starting from the second week
post AI, minimizing the time for resynchronization and rebreeding.
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